NASDAQ:RNA
Avidity Biosciences, Inc.
- Stock
Last Close
29.51
16/05 20:00
Market Cap
956.16M
Beta: −0.10
Volume Today
1.04M
Avg: 1.32M
PE Ratio
−4.46
PFCF: −4.85
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
asset turnover | 0.10 - | 0.02 74.86% | 0.02 15.06% | 0.02 7.30% | 0.01 33.80% | 0.02 5.33% | |
cash conversion cycle | -1.46K - | ||||||
cash per share | 0.15 - | 4.57 2,960.78% | 15.46 237.98% | 11.84 23.37% | 11.71 1.14% | 8.15 30.36% | |
company equity multiplier | -0.10 - | -1.48 1,431.48% | 1.09 173.54% | 1.12 2.81% | 1.11 1.42% | 1.26 13.59% | |
days of inventory outstanding | |||||||
days of payables outstanding | 1.53K - | ||||||
days of sales outstanding | 72.73 - | ||||||
dividend yield | 0.00 - | 0.00 346.60% | |||||
ebit per revenue | -27.70 - | -7.47 73.02% | -6.52 12.71% | -12.66 94.03% | -19.40 53.23% | -24.64 27.05% | |
ebt per ebit | 1.07 - | 1.43 33.57% | 1.00 29.80% | 1.00 0.21% | 0.97 2.71% | 0.90 7.38% | |
effective tax rate | -0.06 - | -0.30 366.54% | 0.01 102.82% | 0.01 35.61% | 0.03 421.99% | ||
enterprise value multiple | -58.99 - | -29.43 50.11% | -5.10 82.68% | -4.99 2.07% | -4.63 7.30% | -2.08 55.06% | |
fixed asset turnover | 0.54 - | 3.68 580.72% | 4.62 25.80% | 0.60 87.06% | 0.61 2.73% | 0.57 6.58% | |
free cash flow per share | -0.47 - | 0.11 123.24% | -1.76 1,717.68% | -2.38 34.87% | -2.67 12.09% | -1.69 36.67% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 0.78 21.98% | |
interest coverage | -14.62 - | -2.35 83.95% | -211.85 8,929.24% | 31.44 - | |||
inventory turnover | |||||||
long term debt to capitalization | -0.23 - | -0.03 84.85% | 0.00 108.92% | 0.03 733.32% | 0.01 49.13% | 0.01 5.34% | |
net income per ebt | 1.06 - | 1.30 22.05% | 0.99 23.64% | 0.99 0.30% | 0.97 2.30% | 1 2.91% | |
net profit margin | -31.49 - | -13.85 56.01% | -6.48 53.21% | -12.59 94.21% | -18.33 45.65% | -22.20 21.11% | |
operating cash flow per share | -0.47 - | 0.12 125.79% | -1.71 1,523.14% | -2.29 33.57% | -2.61 14.15% | -1.63 37.58% | |
operating cycle | 72.73 - | ||||||
operating profit margin | -27.70 - | -7.47 73.02% | -6.52 12.71% | -12.66 94.03% | -19.40 53.23% | -24.64 27.05% | |
payables turnover | 0.24 - | ||||||
pretax profit margin | -29.59 - | -10.67 63.96% | -6.54 38.73% | -12.65 93.62% | -18.86 49.07% | -22.20 17.68% | |
price fair value | -14.33 - | -9.02 37.07% | 1.81 120.02% | 2.58 43.00% | 2.00 22.44% | 1.32 34.10% | |
receivables turnover | 5.02 - | ||||||
return on assets | -3.00 - | -0.33 88.94% | -0.13 60.26% | -0.27 108.39% | -0.26 3.58% | -0.34 27.56% | |
return on capital employed | 16.56 - | -0.20 101.21% | -0.14 30.66% | -0.30 113.95% | -0.30 2.76% | -0.43 41.06% | |
return on equity | 0.29 - | 0.49 69.38% | -0.14 129.22% | -0.31 114.24% | -0.29 4.95% | -0.42 44.89% | |
total debt to capitalization | -0.34 - | -0.08 75.62% | 0.00 103.74% | 0.03 876.91% | 0.02 39.16% | 0.02 6.30% |
All numbers in USD (except ratios and percentages)